Patents by Inventor Disha WANG

Disha WANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted 2-(Pyrrolidine-3-yl)acetic Acid Derivative, Preparation Method and Use Thereof
    Publication number: 20260217689
    Abstract: The invention provides a class of compounds represented by Formula (I), and pharmaceutically acceptable salts thereof. The compounds of the invention have strong inhibitory activity against Lp(a) assembly and can be used to treat cardiovascular diseases (CVDs).
    Type: Application
    Filed: March 6, 2026
    Publication date: July 30, 2026
    Applicant: Innovstone Therapeutics Limited
    Inventors: Yunlong SONG, Wenqing XU, Yang YAO, Hongyan KOU, Linfeng HUANG, Zhiyuan CHEN, Kai LU, Disha WANG, Xiaolin ZHANG, Yongmei LIU
  • Substituted 2-(pyrrolidine-3-yl)acetic acid derivative, preparation method and use thereof
    Publication number: 20250179055
    Abstract: The invention provides a class of compounds represented by Formula (I), and pharmaceutically acceptable salts thereof. The compounds of the invention have strong inhibitory activity against Lp(a) assembly and can be used to treat cardiovascular diseases (CVDs).
    Type: Application
    Filed: November 15, 2024
    Publication date: June 5, 2025
    Applicant: INNOVSTONE THERAPEUTICS LIMITED
    Inventors: Yunlong SONG, Wenqing XU, Yang YAO, Hongyan KOU, Linfeng HUANG, Zhiyuan CHEN, Kai LU, Disha WANG, Xiaolin ZHANG, Yongmei LIU
  • AROMATIC HETEROCYCLIC COMPOUNDS, PREPARATION METHOD THEREFOR AND USES THEREOF
    Publication number: 20250115609
    Abstract: Aromatic heterocyclic compounds as ENPP1 inhibitors, a preparation method therefor and the uses thereof. The compounds have structures as shown in formula (I).
    Type: Application
    Filed: December 15, 2022
    Publication date: April 10, 2025
    Applicant: Innovstone Therapeutics Limited
    Inventors: Yunlong Song, Yuanshu ZHOU, Yiwei FU, Dapei LI, Disha WANG, Hongyan KOU, Liang ZHAO, Kai LU, Weibing DONG, Qingqin LAI
  • AROMATIC HETEROCYCLE-SUBSTITUTED COMPOUNDS, AND PREPARATION METHOD THEREFOR AND USE THEREOF
    Publication number: 20250066350
    Abstract: Disclosed are a class of compounds having a new structure as an ATR inhibitor, and a stereoisomer, an optical isomer, a pharmaceutical salt, a prodrug and a solvate thereof. An in-vitro enzyme inhibitory activity study shows that the compounds have a strong inhibitory effect on an ATR enzyme, and can be used as prospecting compounds for treating ATR-mediated diseases.
    Type: Application
    Filed: December 15, 2022
    Publication date: February 27, 2025
    Applicant: Innovstone Therapeutics Limited
    Inventors: Yunlong Song, Wenqing Xu, Xinyuan MIAO, Kun ZHANG, Dapei LI, Jian CHEN, Wei LI, Kai LU, Hongyan KOU, Disha WANG, Qiangqiang JIANG